A novel full-human CD22-CAR T cell therapy with potent activity against CD22low B-ALL.
Yue TanHaodong CaiChuo LiBiping DengWeiliang SongZhuojun LingGuang HuYongkun YangPanpan NiuGuangrong MengWei ChengJinlong XuJiajia DuanZelin WangXinjian YuXiaoming FengJian-Feng ZhouJing PanPublished in: Blood cancer journal (2021)